Blessing M Fubara
Examiner (ID: 2724, Phone: (571)272-0594 , Office: P/1613 )
Most Active Art Unit | 1613 |
Art Unit(s) | 1613, 1618, 1615 |
Total Applications | 2265 |
Issued Applications | 1176 |
Pending Applications | 331 |
Abandoned Applications | 758 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18871233
[patent_doc_number] => 11859021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Compounds for regulating trained immunity, and their methods of use
[patent_app_type] => utility
[patent_app_number] => 17/698971
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 35085
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698971 | Compounds for regulating trained immunity, and their methods of use | Mar 17, 2022 | Issued |
Array
(
[id] => 18550670
[patent_doc_number] => 20230248670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => APPLICATION OF PREPARATION FOR INHIBITING CAMK2G EXPRESSION IN PREPARATION OF MEDICINE FOR TREATING PSORIASIS
[patent_app_type] => utility
[patent_app_number] => 17/697337
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697337
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697337 | APPLICATION OF PREPARATION FOR INHIBITING CAMK2G EXPRESSION IN PREPARATION OF MEDICINE FOR TREATING PSORIASIS | Mar 16, 2022 | |
Array
(
[id] => 17702824
[patent_doc_number] => 20220202830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE
[patent_app_type] => utility
[patent_app_number] => 17/696319
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696319 | Pharmaceutical compositions of testosterone | Mar 15, 2022 | Issued |
Array
(
[id] => 18064414
[patent_doc_number] => 20220395501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => TREATMENT OF GVHD
[patent_app_type] => utility
[patent_app_number] => 17/692753
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692753 | TREATMENT OF GVHD | Mar 10, 2022 | Pending |
Array
(
[id] => 17928280
[patent_doc_number] => 20220323405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMBINATION PRODUCT USING 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND CARVEDILOL FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/692094
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692094 | COMBINATION PRODUCT USING 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND CARVEDILOL FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | Mar 9, 2022 | Pending |
Array
(
[id] => 17828314
[patent_doc_number] => 20220265618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => METHODS OF TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/675289
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675289 | METHODS OF TREATING PROSTATE CANCER | Feb 17, 2022 | Abandoned |
Array
(
[id] => 17805702
[patent_doc_number] => 20220257537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => DILUTE READY TO USE LARGE VOLUME CONTAINERS OF PHENYLEPHRINE
[patent_app_type] => utility
[patent_app_number] => 17/670620
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/670620 | DILUTE READY TO USE LARGE VOLUME CONTAINERS OF PHENYLEPHRINE | Feb 13, 2022 | Pending |
Array
(
[id] => 17670885
[patent_doc_number] => 20220184052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => COMPOSITION COMPRISING FEXOFENADINE
[patent_app_type] => utility
[patent_app_number] => 17/650663
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650663
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650663 | COMPOSITION COMPRISING FEXOFENADINE | Feb 9, 2022 | Pending |
Array
(
[id] => 17625712
[patent_doc_number] => 20220160727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHOD FOR THE TREATMENT OF DRAVET SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/667136
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667136
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667136 | METHOD FOR THE TREATMENT OF DRAVET SYNDROME | Feb 7, 2022 | Pending |
Array
(
[id] => 17593468
[patent_doc_number] => 20220143041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => COMBINED THERAPY FOR NMDAR ANTAGONIST-RESPONSIVE NEUROPSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/586828
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586828
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586828 | COMBINED THERAPY FOR NMDAR ANTAGONIST-RESPONSIVE NEUROPSYCHIATRIC DISORDERS | Jan 27, 2022 | Pending |
Array
(
[id] => 17609689
[patent_doc_number] => 20220151968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHODS FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME
[patent_app_type] => utility
[patent_app_number] => 17/587197
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587197
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/587197 | METHODS FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME | Jan 27, 2022 | Pending |
Array
(
[id] => 17748064
[patent_doc_number] => 20220226267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Application of CaMK4 in Preparation of Medicine for Preventing and Treating psoriasis
[patent_app_type] => utility
[patent_app_number] => 17/577156
[patent_app_country] => US
[patent_app_date] => 2022-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17577156
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/577156 | Application of CaMK4 in Preparation of Medicine for Preventing and Treating psoriasis | Jan 16, 2022 | Pending |
Array
(
[id] => 17702936
[patent_doc_number] => 20220202942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/571804
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/571804 | BIODEGRADABLE DRUG DELIVERY COMPOSITIONS | Jan 9, 2022 | Pending |
Array
(
[id] => 17850486
[patent_doc_number] => 20220280527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/569002
[patent_app_country] => US
[patent_app_date] => 2022-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569002
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/569002 | TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT | Jan 4, 2022 | Pending |
Array
(
[id] => 17821446
[patent_doc_number] => 11426369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 17/556904
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19005
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556904 | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same | Dec 19, 2021 | Issued |
Array
(
[id] => 17821446
[patent_doc_number] => 11426369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 17/556904
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19005
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556904 | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same | Dec 19, 2021 | Issued |
Array
(
[id] => 17685780
[patent_doc_number] => 20220193072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADER
[patent_app_type] => utility
[patent_app_number] => 17/548842
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17548842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/548842 | METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADER | Dec 12, 2021 | Pending |
Array
(
[id] => 17670867
[patent_doc_number] => 20220184034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS FOR TREATING CUTANEOUS METASTATIC CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/546715
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546715 | METHODS FOR TREATING CUTANEOUS METASTATIC CANCERS | Dec 8, 2021 | Pending |
Array
(
[id] => 17625656
[patent_doc_number] => 20220160671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => ANTIVIRAL THERAPEUTIC COMPOUNDS AND COMPOSITIONS FOR USE IN TREATMENT OF CORONAVIRUS AND INFLUENZA VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/533528
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533528 | Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus | Nov 22, 2021 | Issued |
Array
(
[id] => 17625591
[patent_doc_number] => 20220160606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => PERSONAL CARE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/529427
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/529427 | PERSONAL CARE COMPOSITION | Nov 17, 2021 | Pending |